Apotheek Leupe SRL
Apotheek Leupe reported total assets of 738,801 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jan 2026).
The score of Apotheek Leupe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Leupe's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 13,795 € | ||||
| Equity | 141,756 € | ||||
| Cash | 2,763 € | ||||
| EBITDA | 113,371 € | ||||
| Total assets | 738,801 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 02 Jan 2026
- Year ended 30 Jun 2024filed on 22 Jan 2025
- Year ended 30 Jun 2023filed on 02 Feb 2024
- Year ended 30 Jun 2022filed on 10 Jan 2023
- Year ended 30 Jun 2021filed on 05 Jan 2022
Apotheek Leupe's financial analysis
- Solvency19.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Leupe
Apotheek Leupe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0886.646.316
- VAT number
- BE0886646316
- Peppol
- Registered · 0208:0886646316 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 2007
- Registered office
- 8760 Tielt
- Latest accounts
- 2025 · filed on 02 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Leupe (SRL) has been based in Tielt since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 13,795 € and equity of 141,756 €; its revenue is not published. Its solvency stands at 19.2%, below the median of its sector (44.2%).
Companies similar to Apotheek Leupe
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Coenen Estelle Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 738,970 €
- D'Huyvetter - Vandermarliere Retail sale of pharmaceutical products Zulte · balance sheet 737,810 €
- Sdsphar Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 740,622 €
- Apoteek Verlinde Retail sale of pharmaceutical products Dentergem · balance sheet 734,257 €
- SOBEN Pharma Station Retail sale of pharmaceutical products Esneux · balance sheet 732,996 €
- NB Pharma Retail sale of pharmaceutical products Nieuwpoort · balance sheet 745,538 €
- Falipharma Retail sale of pharmaceutical products Sambreville · balance sheet 731,975 €
- Depasse - Schonne Pharmacie Retail sale of pharmaceutical products Éghezée · balance sheet 747,279 €
Frequently asked questions about Apotheek Leupe
What is the revenue of Apotheek Leupe?
Apotheek Leupe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Leupe?
In Belgium, the VAT number is the company number prefixed with BE: BE0886646316 for Apotheek Leupe, if the company is VAT-registered. Its company number (CBE) is 0886.646.316.
Where is the registered office of Apotheek Leupe?
According to the CBE register, the registered office of Apotheek Leupe is in 8760 Tielt.
What is the equity of Apotheek Leupe?
At the close of the 2025 financial year, the equity of Apotheek Leupe amounts to 141,756 €, a solvency of 19.2% of total assets.
Who manages Apotheek Leupe?
The register lists 1 active mandates at Apotheek Leupe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Leupe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →